0001720420-23-000009.txt : 20230913 0001720420-23-000009.hdr.sgml : 20230913 20230913165057 ACCESSION NUMBER: 0001720420-23-000009 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230913 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230913 DATE AS OF CHANGE: 20230913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IBEX Ltd CENTRAL INDEX KEY: 0001720420 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38442 FILM NUMBER: 231253246 BUSINESS ADDRESS: STREET 1: 1717 PENNSYLVANIA AVENUE NW STREET 2: SUITE 825 CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: (202)580-6200 MAIL ADDRESS: STREET 1: 1717 PENNSYLVANIA AVENUE NW STREET 2: SUITE 825 CITY: WASHINGTON STATE: DC ZIP: 20006 FORMER COMPANY: FORMER CONFORMED NAME: IBEX Holdings Ltd DATE OF NAME CHANGE: 20171023 8-K 1 ibex-20230913.htm 8-K ibex-20230913
FALSE000172042000017204202023-09-132023-09-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
____________________________________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 13, 2023
____________________________________________________________
IBEX Limited
(Exact name of registrant as specified in its charter)
____________________________________________________________
Bermuda001-3844200-0000000
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
1717 Pennsylvania Avenue NW, Suite 825
Washington, District of Columbia 20006
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (202) 580-6200
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common shares, par value of $0.0001IBEXNasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company               x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.               o



Item 2.02. Results of Operations and Financial Condition.

On September 13, 2023, IBEX Limited issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2023.

A copy of the September 13, 2023 press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.

The information in this Item 2.02, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.


Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

EXHIBIT INDEX

Exhibit No.         Description
99.1         Press release announcing financial results for fourth quarter and fiscal year ended June 30, 2023,
dated September 13, 2023
104         Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IBEX LIMITED
(Registrant)
Date: September 13, 2023/s/ Robert Dechant
(Signature)
Name:Robert Dechant
Title:Chief Executive Officer

EX-99.1 2 ibex-20230913_erxexx991.htm EX-99.1 Document

Exhibit 99.1
image_0.jpg
IBEX Announces Record Fourth Quarter and Fiscal Year 2023 Financial Results
WASHINGTON, DC— September 13, 2023—IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its fourth quarter and fiscal year ended June 30, 2023.

Key Fiscal Year 2023 Highlights
Fiscal year 2023 revenue increased 6.1% over the prior year period to $523.1 million, with a continued migration from onshore to higher margin offshore and nearshore regions.
Revenue generated from BPO 2.0 clients grew at an accelerated rate and increased 18.5% for fiscal year 2023. These clients represented 77% of revenue for the fiscal year.
Ten new client relationships were established across the HealthTech, Retail & E-Commerce, Travel, Transportation & Logistics, and Technology verticals during fiscal year 2023.
Fiscal year 2023 GAAP net income and diluted earnings per share increased to $31.6 million and $1.67 from $21.5 million and $1.15 in the prior year, respectively. Net income margins in the full year were 6.0%, an increase of 168 bps for the year.
Fiscal year 2023 adjusted net income and adjusted earnings per share increased to $36.9 million and $1.96 from $26.0 million and $1.39 in the prior year.
Fiscal year 2023 adjusted EBITDA increased 48.8% to $66.6 million, over the prior year. Adjusted EBITDA margins in the full year were 12.7%, an increase of 360 bps for the year.
Capacity utilization increased to 77% at June 30, 2023 from approximately 69% at June 30, 2022, contributing to the significant margin improvement.
Net cash position improved to $56.4 million as of June 30, 2023 from $33.1 million as of June 30, 2022 due to strong free cash flow generated throughout the year (see Exhibit 4 for reconciliation).
Results in line with guidance on a US GAAP basis.

Key Fourth Quarter 2023 Highlights
Fourth quarter revenue increased 0.7% to $124.4 million over the prior year quarter.
Fourth quarter GAAP net income and diluted earnings per share declined to $4.5 million, and $0.24 compared to $6.4 million, and $0.35 in the prior year quarter, driven largely by the absence of a one-time deferred tax benefit in the prior year quarter. Net income margin was 3.6% compared to 5.2% in the prior year quarter.
Fourth quarter adjusted net income and adjusted earnings per share declined to $6.2 million and $0.33 compared to $8.3 million and $0.45 in the prior year quarter, driven largely by the absence of a one-time deferred tax benefit in prior year quarter.
Fourth quarter non-GAAP adjusted EBITDA increased 21.0% to $15.4 million, over the prior year quarter.
Adjusted EBITDA margins in the fourth quarter were 12.4%, +210 bps in the quarter.

“In the face of a challenging macro-environment, ibex delivered outstanding financial results in fiscal year 2023,” said Bob Dechant, CEO of ibex. “Our business grew at 6% annually, driven by new wins with blue chip clients in our strategic verticals, while adjusted EBITDA grew at an impressive 49%. We made meaningful progress on growth in our key HealthTech and Retail & E-Commerce verticals, as well as our geographic footprint and capacity utilization.” Dechant continued, “We finished the year with continued strong margin expansion and have our pipeline and sales funnel in a great position. Additionally, with our leadership position in developing AI based solutions, I am very optimistic about the long-term trajectory of ibex in fiscal year 2024 and beyond.”




Domestic filing status and US GAAP conversion
As of July 1, 2023, we became a domestic filer and are reporting our financial results in accordance with US GAAP, rather than IFRS. The two significant accounting impacts from this change are in lease and warrant accounting. Among the impacts, this results in a reduction in reported debt of $77.9 million as of June 30, 2023, a reduction in fourth quarter and fiscal year 2023 reported revenue of $0.02 million and $0.2 million, respectively, and a reduction in reported fourth quarter and fiscal year 2023 adjusted EBITDA of $5.3 million and $21.9 million, respectively, compared to what would have been reported under IFRS. When these impacts are factored into our previously provided guidance issued under IFRS, the results align with our previous guidance.

Fiscal Year 2023 Financial Performance
Revenue
Revenue increased 6.1% to $523.1 million compared to $492.9 million in the prior year as we successfully grew in our strategic verticals while replacing a large legacy technology client.
Revenue growth was primarily driven by strength in our HealthTech, Retail & E-Commerce, Travel and Transportation & Logistics verticals.
The Telecom vertical now represents 16.3% of our annual revenue, compared to 18.1% in the prior year, as we continue diversifying our client base.

Net Income and Earnings Per Share
Net income and diluted earnings per share increased to $31.6 million and $1.67, respectively, compared to $21.5 million and $1.15, respectively, in the prior year. The improvement was primarily driven by stronger operating results from higher capacity utilization and an increased mix of higher margin nearshore and offshore delivery.
Net income margin was 6.0%, compared to 4.4% in the prior year.
Non-GAAP adjusted net income and diluted adjusted earnings per share increased to $36.9 million and $1.96, respectively, compared to $26.0 million and $1.39, respectively, in the prior year (see Exhibit 1 for reconciliation).

Adjusted EBITDA
Adjusted EBITDA increased to $66.6 million, compared to $44.7 million in the prior year (see Exhibit 2 for reconciliation), driven by stronger operating results from higher capacity utilization and an increased mix of higher margin nearshore and offshore delivery.
Adjusted EBITDA margin was 12.7%, compared to 9.1% in the prior year (see Exhibit 2 for reconciliation).

Fourth Quarter Financial Performance
Revenue
Revenue increased 0.7% to $124.4 million, compared to $123.5 million in the prior year quarter. Revenue growth was driven by 10% growth in our higher margin near and offshore regions, offset by lower onshore revenue, and was moderated by prevailing macroeconomic market conditions. Revenues in our higher margin offshore and nearshore regions represented 73.9% of revenue mix for the quarter versus 67.8% in the prior year quarter.
Revenue related to our BPO 2.0 clients grew 7.0% compared to the prior year quarter and now represents 78.8% of our quarterly revenue.
Net Income and Earnings Per Share
Net income decreased to $4.5 million compared to $6.4 million in the prior year quarter. Diluted earnings per share decreased to $0.24 compared to $0.35 in the prior year quarter. The decrease was primarily the result of higher taxes due to the absence of a one-time tax benefit in the prior year quarter.
Net income margin decreased to 3.6% compared to 5.2% in the prior year quarter.
Non-GAAP adjusted net income was $6.2 million, compared to $8.3 million in the prior year quarter. Non-GAAP adjusted diluted earnings per share decreased to $0.33, compared to $0.45 in the prior



year quarter (see Exhibit 1 for reconciliation). The decline was largely the result of a one-time tax benefit in the prior year quarter.
Adjusted EBITDA
Adjusted EBITDA increased to $15.4 million, compared to $12.8 million in the prior year quarter (see Exhibit 2 for reconciliation), driven by stronger operating results from higher capacity utilization and an increased mix of higher margin nearshore and offshore delivery.
Adjusted EBITDA margin increased to 12.4%, compared to 10.3% in the prior year quarter (see Exhibit 2 for reconciliation).

Fiscal 2023 Year End Cash Flow and Balance Sheet
Cash flow from operations increased to $41.9 million, compared to $40.0 million in the prior year. The increase was primarily driven by improvements in operating results, offset by higher working capital requirements.
Capital expenditures were $19.0 million compared to $25.9 million in the prior year.
Full year free cash flow increased to $22.9 million, compared to $14.1 million in the prior year (see Exhibit 3 for reconciliation).
Cash and cash equivalents improved to $57.4 million and availability on our revolving credit facilities was $71.9 million as of June 30, 2023, compared to cash and cash equivalents of $48.8 million and availability on our revolving credit facilities of $50.5 million as of June 30, 2022.
Total debt was $1.0 million as of June 30, 2023, compared to total debt of $15.7 million last year.
Net cash position improved to $56.4 million as of June 30, 2023 from $33.1 million as of June 30, 2022 (see Exhibit 4 for reconciliation).

Fiscal Year and First Quarter Fiscal 2024 Business Outlook
“Looking ahead to fiscal year 2024, while the sales pipeline remains healthy, we expect the macroeconomic environment and trend toward lower cost, higher margin regions will continue to impact revenue growth. The impact of the operational improvements we’ve made to our business and margin structure will carry forward, which enables us to further invest in our infrastructure for the future, as we focus on revenue growth and continued EBITDA margin expansion” said Taylor Greenwald, CFO of ibex. “We view ibex as a business that will resume to historical growth rates with continued margin expansion over the longer term.”

•     For fiscal year 2024 revenue is expected to be in the range of $525 to $535 million, representing low single-digit growth. Adjusted EBITDA margin should increase to approximately 13%.
For the first quarter fiscal 2024 revenue is expected to be in the range of $122 to $125 million, reflective of the macroeconomic impacts. Adjusted EBITDA margin should increase to approximately 11% versus 10% in the prior year quarter on a US GAAP basis.
•     Fiscal year 2024 capital expenditures are expected to be in the range of $15 to $20 million.

Conference Call and Webcast Information
IBEX Limited will host a conference call and live webcast to discuss its fourth quarter of fiscal year 2023 financial results at 4:30 p.m. eastern time today, September 13, 2023. The conference e-call may be accessed by registering at https://register.vevent.com/register/BI360e09e5236c413881035854d5dffaff. We will also post to this section of our website the earning slides, which will accompany our conference call and live webcast, and encourage you to review the information that we make available on our website.
Live and archived webcasts can be accessed at: https://investors.ibex.co/.
Financial Information
This announcement does not contain sufficient information to constitute an interim financial report as defined in Financial Accounting Standards ASC 270, “Interim Financial Reporting.” The financial information in this press release has not been audited.



Non-GAAP Financial Measures
We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures provide a more accurate depiction of the performance of the business by encompassing only relevant and manageable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our operating results as reported under GAAP as issued by the Financial Accounting Standards Board (“FASB”). Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under GAAP as issued by the FASB and should not be considered as alternatives to operating profit or net income or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with GAAP as issued by the FASB or any other generally accepted accounting principles.
ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA margin to the most directly comparable GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, fair value adjustments, and share-based compensation expense. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period.
About ibex
ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.
Forward Looking Statements
In addition to historical information, this release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: our ability to attract new business and retain key clients; our profitability based on our utilization, pricing and managing costs; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities and current trends toward outsourcing services may reverse; our ability to manage our international operations, particularly in the Philippines, Jamaica, Pakistan and Nicaragua; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security, employment and anti-corruption; the effect of cyberattacks or cybersecurity vulnerabilities on our information technology systems; our ability to realize the anticipated strategic and financial benefits of our relationship with Amazon; and other factors discussed in the “Risk Factors” described in our periodic reports filed with the U.S. Securities and Exchange Commission (“SEC”), including our annual reports on Form 10-K, quarterly reports on Form 10-Q, and past filings on Form 20-F, and any other risk factors we include in subsequent filings with the SEC. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we



undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

IR Contact:  Michael Darwal, EVP, Deputy CFO & Investor Relations, ibex, michael.darwal@ibex.co
Media Contact:  Daniel Burris, Senior Director PR and Communication, ibex, daniel.burris@ibex.co



IBEX Limited
Unaudited Consolidated Statements of Financial Position
($000s)June 30,
2023
June 30,
2022
Assets
Current assets
Cash and cash equivalents$57,429 $48,831 
Accounts receivable86,364 75,418 
Prepaid expenses6,616 7,135 
Due from related parties43 13 
Tax advances and receivables5,965 6,390 
Other current assets2,190 4,564 
Total current assets158,607 142,351 
Non-current assets
Property and equipment, net41,151 41,939 
Operating lease assets70,919 83,094 
Goodwill11,832 11,832 
Deferred tax asset, net4,585 9,276 
Other non-current assets6,230 5,688 
Total non-current assets134,717 151,829 
Total assets$293,324 $294,180 
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued liabilities$18,705 $21,286 
Accrued payroll and employee-related liabilities29,360 33,453 
Current deferred revenue6,413 8,600 
Current operating lease liabilities13,036 13,808 
Current maturities of long-term debt413 15,079 
Due to related parties2,314 2,583 
Income taxes payable3,020 2,965 
Total current liabilities73,261 97,774 
Non-current liabilities
Non-current deferred revenue1,383 3,993 
Non-current operating lease liabilities64,854 75,994 
Long-term debt600 661 
Other non-current liabilities3,262 2,299 
Total non-current liabilities70,099 82,947 
Total liabilities143,360 180,721 
Stockholders' equity
Common stock
Additional paid-in capital204,734 197,785 
Treasury stock(3,682)(3,406)
Accumulated other comprehensive loss(6,312)(4,562)
Accumulated deficit(44,778)(76,360)
Total stockholders' equity149,964 113,459 
Total liabilities and stockholders' equity$293,324 $294,180 



IBEX Limited
Unaudited Consolidated Statements of Comprehensive Income
Three months ended June 30,Twelve months ended June 30,
(000s, except per share amounts)2023202220232022
Revenue$124,431 $123,537 $523,118 $492,851 
Cost of services87,356 91,779 374,992 373,973 
Selling, general and administrative23,717 21,278 88,663 80,153 
Depreciation and amortization5,052 5,014 18,985 18,100 
Total operating expenses116,125 118,071 482,640 472,226 
Income from operations8,306 5,466 40,478 20,625 
Interest income / (expense), net10 (169)(152)(1,246)
Income before income taxes8,316 5,297 40,326 19,379 
Provision for income tax (expense) / benefit(3,806)1,124 (8,744)2,077 
Net income$4,510 $6,421 $31,582 $21,456 
Other comprehensive income
Foreign currency translation adjustments$(72)$(1,265)$(2,234)$(2,281)
Cash flow hedge revaluation, net of tax(254)(202)515 (323)
Actuarial (loss) / gain on defined benefit plan(31)440 (31)440 
Total other comprehensive (loss) / income(357)(1,027)(1,750)(2,164)
Total comprehensive income$4,153 $5,394 $29,832 $19,292 
Net income per share
Basic earnings per share$0.25 $0.35 $1.74 $1.18 
Diluted earnings per share$0.24 $0.35 $1.67 $1.15 
Weighted average common shares outstanding
Basic18,25918,14818,20018,232
Diluted18,98918,55518,89318,724



IBEX Limited
Unaudited Consolidated Statements of Cash Flows
Three months ended June 30,Twelve months ended June 30,
($000s)2023202220232022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income$4,510 $6,421 $31,582 $21,456 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization5,052 5,014 18,985 18,100 
Noncash lease expense3,510 3,624 14,456 14,066 
Warrant contra revenue234 259 1,090 970 
Deferred income tax1,511 (2,614)4,529 (5,170)
Share-based compensation expense633 555 4,606 1,851 
Allowance of expected credit losses190 (62)295 — 
Loss on lease terminations251 — 251 — 
Gain on sale of subsidiaries— — (246)— 
Change in assets and liabilities:
(Increase) / decrease in accounts receivable5,549 11,013 (12,297)(9,705)
Decrease / (increase) in prepaid expenses and other current assets(775)1,841 1,467 3,551 
Increase / (decrease) in accounts payable and accrued liabilities2,324 3,369 (3,753)2,307 
Increase / (decrease) in deferred revenue(2,076)(823)(4,797)5,506 
Decrease in operating lease liabilities(3,478)(3,407)(14,309)(12,926)
Net cash inflow from operating activities17,435 25,190 41,859 40,006 
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment(3,721)(2,708)(18,952)(25,919)
Cash outflow from sale of subsidiaries, net of cash received— — (85)— 
Net cash outflow from investing activities(3,721)(2,708)(19,037)(25,919)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from line of credit58 12,901 43,448 88,117 
Repayments of line of credit(56)(24,500)(54,597)(99,227)
Repayment of debt— (1,411)(3,795)(6,834)
Proceeds from the exercise of options226 17 2,053 35 
Principal payments on finance leases(94)(73)(447)(818)
Purchase of treasury shares— (1,064)(276)(3,406)
Net cash (outflow) / inflow from financing activities134 (14,130)(13,614)(22,133)
Effects of exchange rate difference on cash and cash equivalents(95)(971)(610)(965)
Net (decrease) / increase in cash and cash equivalents13,753 7,381 8,598 (9,011)
Cash and cash equivalents at beginning of the period43,676 41,450 48,831 57,842 
Cash and cash equivalents at end of the year$57,429 $48,831 $57,429 $48,831 



IBEX Limited
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
EXHIBIT 1: Adjusted net income and adjusted earnings per share
We define “adjusted net income” as net income before the effect of the following items: non-recurring expenses (including domestic filer conversion, severance, legal and settlement, and Pandemic costs, as applicable), warrant contra revenue, foreign currency gains or losses, share-based compensation expense, gain or loss on sale of subsidiaries and lease terminations, net of the tax impact of such adjustmentsWe define “adjusted earnings per share” as diluted earnings per share less the per share impact of adjustments to net income. The following table provides a reconciliation of net income to adjusted net income and diluted earnings per share to adjusted earnings per share for the periods presented:
Three months ended June 30,  Twelve months ended June 30, 
($000s, except per share amounts)2023202220232022
Net income$4,510 $6,421 $31,582 $21,456 
Net income margin3.6 %5.2 %6.0 %4.4 %
Non-recurring expenses1,348 1,502 2,224 3,256 
Warrant contra revenue234 259 1,090 970 
Foreign currency gain(379)(34)(801)(57)
Share-based compensation expense633 555 4,606 1,851 
Gain on sale of subsidiaries— — (246)— 
Gain on lease terminations251 — 251 — 
Total adjustments$2,087 $2,282 $7,124 $6,020 
Tax impact of adjustments1(370)(416)(1,760)(1,427)
Adjusted net income$6,227 $8,287 $36,946 $26,049 
Adjusted net income margin5.0 %6.7 %7.1 %5.3 %
Diluted earnings per share$0.24 $0.35 $1.67 $1.15 
Per share impact of adjustments to net income0.09 0.10 0.28 0.25 
Adjusted earnings per share$0.33 $0.45 $1.96 $1.39 
Weighted average diluted shares outstanding18,989 18,555 18,893 18,724 
1The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdictions.



EXHIBIT 2:  EBITDA, adjusted EBITDA, and adjusted EBITDA margin
We define “EBITDA” as net income before the effect of the following items: interest (income) / expense, net, income tax expense / (benefit), and depreciation and amortization. We define “adjusted EBITDA” as EBITDA before the effect of the following items: non-recurring expenses (including domestic filer conversion, severance, legal and settlement, and Pandemic costs, as applicable), warrant contra revenue, foreign currency gains, share-based compensation expense, gain on disposal of subsidiaries and lease terminations. Adjusted EBITDA margin is a non-GAAP profitability measure that represents adjusted EBITDA divided by revenue. The following table provides a reconciliation of net income to adjusted EBITDA for the periods presented:
Three months ended June 30,  Twelve months ended June 30, 
($000s)2023202220232022
Net income$4,510 $6,421 $31,582 $21,456 
Net income margin3.6 %5.2 %6.0 %4.4 %
Interest (income) / expense, net(10)169 152 1,246 
Income tax expense / (benefit)3,806 (1,124)8,744 (2,077)
Depreciation and amortization5,052 5,014 18,985 18,100 
EBITDA$13,358 $10,480 $59,463 $38,725 
Non-recurring expenses1,348 1,502 2,224 3,256 
Warrant contra revenue234 259 1,090 970 
Foreign currency gain(379)(34)(801)(57)
Share-based compensation expense633 555 4,606 1,851 
Gain on sale of subsidiaries— — (246)— 
Gain on lease terminations251 — 251 — 
Adjusted EBITDA$15,445 $12,762 $66,587 $44,745 
Adjusted EBITDA margin12.4 %10.3 %12.7 %9.1 %




EXHIBIT 3: Free cash flow
We define “free cash flow” as net cash provided by operating activities less capital expenditures.
Three months ended June 30,  Twelve months ended June 30, 
2023202220232022
($000s)
Net cash provided by operating activities$17,435 $25,190 $41,859 $40,006 
Less: capital expenditures3,721 2,707 18,952 25,919 
Free cash flow$13,714 $22,483 $22,907 $14,087 

EXHIBIT 4: Net cash
We define “net cash” as total cash and cash equivalents less debt.
($000s)June 30,
2023
June 30,
2022
Cash and cash equivalents$57,429 $48,831 
Debt
Current$413 $15,079 
Non-current600 661 
Total debt$1,013 $15,740 
Net cash$56,416 $33,091 

EX-101.SCH 3 ibex-20230913.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ibex-20230913_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 5 ibex-20230913_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_0.jpg begin 644 image_0.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Sep. 13, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 13, 2023
Entity Registrant Name IBEX Limited
Entity Incorporation, State or Country Code D0
Entity File Number 001-38442
Entity Tax Identification Number 00-0000000
Entity Address, Address Line One 1717 Pennsylvania Avenue NW
Entity Address, Address Line Two Suite 825
Entity Address, City or Town Washington
Entity Address, State or Province DC
Entity Address, Postal Zip Code 20006
City Area Code 202
Local Phone Number 580-6200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares, par value of $0.0001
Trading Symbol IBEX
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Flag false
Entity Central Index Key 0001720420
XML 8 ibex-20230913_htm.xml IDEA: XBRL DOCUMENT 0001720420 2023-09-13 2023-09-13 false 0001720420 8-K 2023-09-13 IBEX Limited D0 001-38442 00-0000000 1717 Pennsylvania Avenue NW Suite 825 Washington DC 20006 202 580-6200 false false false false Common shares, par value of $0.0001 IBEX NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

JQ"(6,P$ "(" / M " 740 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " !&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'-02P$"% ,4 " ! XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 24 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://ibex.co/role/Cover Cover Cover 1 false false All Reports Book All Reports ibex-20230913.htm ibex-20230913.xsd ibex-20230913_erxexx991.htm ibex-20230913_lab.xml ibex-20230913_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ibex-20230913.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "ibex-20230913.htm" ] }, "labelLink": { "local": [ "ibex-20230913_lab.xml" ] }, "presentationLink": { "local": [ "ibex-20230913_pre.xml" ] }, "schema": { "local": [ "ibex-20230913.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ibex", "nsuri": "http://ibex.co/20230913", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ibex-20230913.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ibex.co/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ibex-20230913.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ibex.co/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001720420-23-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001720420-23-000009-xbrl.zip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end